Friday, July 15, 2022 10:45:56 AM
...should show how good leronlimab is ...
...should be VERY impressive for leronlimab...
...should improve...
...to be remove or reduced with leronlmab...
...should have impressive results ...
A healthy dose of facts in a sea of unrealistic expectations:
every previous 50 times a prediction has been made about Leronlimab which "should have" impressive results, it has FAILED to meet any regulator or partner's expectation.
Failures each time, everywhere, in more than 7 countries. The entire last 4 years. The entire last 20 years also.
Consequently, naive investors should apply an extra dose of scepticism.
That's REALITY
Recent CYDY News
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
